Impact of graft hepatic vein inferior vena cava reconstruction with graft venoplasty and inferior vena cava cavoplasty in living donor adult liver transplantation using a left lobe graft

Taketoshi Suehiro, Mitsuo Shimada, Keiji Kishikawa, Tatsuo Shimura, Yuji Soejima, Tomoharu Yoshizumi, Kohji Hashimoto, Yasushi Mochida, Yoshihiko Maehara, Hiroyukl Kuwano

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Background. Hepatic venous reconstruction is critical in living donor adult liver transplantation (LDALT) because outflow obstruction in small for size graft may lead to graft dysfunction or loss. We describe the usefulness of venoplasties of the graft hepatic vein (HV) and graft HV-recipient inferior vena cava (IVC) reconstruction in LDALT using a left lobe graft. Methods. Sixty patients who underwent LDALT were studied. We divided the patients into following two groups: venoplasty group (n=30) and control group (n=30). For the patients with venoplasty group, venoplasty of the graft and recipient IVC cavoplasty was made to widen the orifice. Comparison examination of a background factors and postoperative bilirubin and the ascites was carried out. Results. The mean graft volume standard liver volume ratio (GV/SLV) did not have the difference at 41.7% of venoplasty group, and 42.1% of control group (p=NS). The diameter of the hepatic vein in control and venoplasty group before and after venoplasty is 26.9±5.5, 28.2±2.9, and 34.1±3.9 mm, respectively. The diameter of the hepatic vein after venoplasty is larger than that of before venoplasty and of control (P<0.05). Mean total bilirubin level on postoperative day (POD) 7 is 13.8±9.3 mg/dl in control group and 7.0±3.3 mg/dl in venoplasty group (P<0.05). Mean amount of ascites on POD 7 and 14 are 1576±1113 and 1397±1661 cc in control group, and 736±416 and 550±385 cc in venoplasty group, respectively (P<0.05). Two-year survival rate is 75.2% in control group and 86.6% in venoplasty group (P<0.05). Conclusions. We conclude that in LDALT using left lobe graft, HV-IVC reconstruction with graft venoplasty and IVC cavoplasty is useful not only to prevent outflow block but also to improve graft function.

Original languageEnglish
Pages (from-to)964-968
Number of pages5
JournalTransplantation
Volume80
Issue number7
DOIs
Publication statusPublished - Oct 15 2005

Fingerprint

Hepatic Veins
Living Donors
Inferior Vena Cava
Liver Transplantation
Transplants
Control Groups
Bilirubin
Ascites
Liver
Survival Rate

All Science Journal Classification (ASJC) codes

  • Transplantation

Cite this

Impact of graft hepatic vein inferior vena cava reconstruction with graft venoplasty and inferior vena cava cavoplasty in living donor adult liver transplantation using a left lobe graft. / Suehiro, Taketoshi; Shimada, Mitsuo; Kishikawa, Keiji; Shimura, Tatsuo; Soejima, Yuji; Yoshizumi, Tomoharu; Hashimoto, Kohji; Mochida, Yasushi; Maehara, Yoshihiko; Kuwano, Hiroyukl.

In: Transplantation, Vol. 80, No. 7, 15.10.2005, p. 964-968.

Research output: Contribution to journalArticle

Suehiro, Taketoshi ; Shimada, Mitsuo ; Kishikawa, Keiji ; Shimura, Tatsuo ; Soejima, Yuji ; Yoshizumi, Tomoharu ; Hashimoto, Kohji ; Mochida, Yasushi ; Maehara, Yoshihiko ; Kuwano, Hiroyukl. / Impact of graft hepatic vein inferior vena cava reconstruction with graft venoplasty and inferior vena cava cavoplasty in living donor adult liver transplantation using a left lobe graft. In: Transplantation. 2005 ; Vol. 80, No. 7. pp. 964-968.
@article{7e5b501b845246868620d292037a8ca6,
title = "Impact of graft hepatic vein inferior vena cava reconstruction with graft venoplasty and inferior vena cava cavoplasty in living donor adult liver transplantation using a left lobe graft",
abstract = "Background. Hepatic venous reconstruction is critical in living donor adult liver transplantation (LDALT) because outflow obstruction in small for size graft may lead to graft dysfunction or loss. We describe the usefulness of venoplasties of the graft hepatic vein (HV) and graft HV-recipient inferior vena cava (IVC) reconstruction in LDALT using a left lobe graft. Methods. Sixty patients who underwent LDALT were studied. We divided the patients into following two groups: venoplasty group (n=30) and control group (n=30). For the patients with venoplasty group, venoplasty of the graft and recipient IVC cavoplasty was made to widen the orifice. Comparison examination of a background factors and postoperative bilirubin and the ascites was carried out. Results. The mean graft volume standard liver volume ratio (GV/SLV) did not have the difference at 41.7{\%} of venoplasty group, and 42.1{\%} of control group (p=NS). The diameter of the hepatic vein in control and venoplasty group before and after venoplasty is 26.9±5.5, 28.2±2.9, and 34.1±3.9 mm, respectively. The diameter of the hepatic vein after venoplasty is larger than that of before venoplasty and of control (P<0.05). Mean total bilirubin level on postoperative day (POD) 7 is 13.8±9.3 mg/dl in control group and 7.0±3.3 mg/dl in venoplasty group (P<0.05). Mean amount of ascites on POD 7 and 14 are 1576±1113 and 1397±1661 cc in control group, and 736±416 and 550±385 cc in venoplasty group, respectively (P<0.05). Two-year survival rate is 75.2{\%} in control group and 86.6{\%} in venoplasty group (P<0.05). Conclusions. We conclude that in LDALT using left lobe graft, HV-IVC reconstruction with graft venoplasty and IVC cavoplasty is useful not only to prevent outflow block but also to improve graft function.",
author = "Taketoshi Suehiro and Mitsuo Shimada and Keiji Kishikawa and Tatsuo Shimura and Yuji Soejima and Tomoharu Yoshizumi and Kohji Hashimoto and Yasushi Mochida and Yoshihiko Maehara and Hiroyukl Kuwano",
year = "2005",
month = "10",
day = "15",
doi = "10.1097/01.tp.0000173776.66867.f5",
language = "English",
volume = "80",
pages = "964--968",
journal = "Transplantation",
issn = "0041-1337",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Impact of graft hepatic vein inferior vena cava reconstruction with graft venoplasty and inferior vena cava cavoplasty in living donor adult liver transplantation using a left lobe graft

AU - Suehiro, Taketoshi

AU - Shimada, Mitsuo

AU - Kishikawa, Keiji

AU - Shimura, Tatsuo

AU - Soejima, Yuji

AU - Yoshizumi, Tomoharu

AU - Hashimoto, Kohji

AU - Mochida, Yasushi

AU - Maehara, Yoshihiko

AU - Kuwano, Hiroyukl

PY - 2005/10/15

Y1 - 2005/10/15

N2 - Background. Hepatic venous reconstruction is critical in living donor adult liver transplantation (LDALT) because outflow obstruction in small for size graft may lead to graft dysfunction or loss. We describe the usefulness of venoplasties of the graft hepatic vein (HV) and graft HV-recipient inferior vena cava (IVC) reconstruction in LDALT using a left lobe graft. Methods. Sixty patients who underwent LDALT were studied. We divided the patients into following two groups: venoplasty group (n=30) and control group (n=30). For the patients with venoplasty group, venoplasty of the graft and recipient IVC cavoplasty was made to widen the orifice. Comparison examination of a background factors and postoperative bilirubin and the ascites was carried out. Results. The mean graft volume standard liver volume ratio (GV/SLV) did not have the difference at 41.7% of venoplasty group, and 42.1% of control group (p=NS). The diameter of the hepatic vein in control and venoplasty group before and after venoplasty is 26.9±5.5, 28.2±2.9, and 34.1±3.9 mm, respectively. The diameter of the hepatic vein after venoplasty is larger than that of before venoplasty and of control (P<0.05). Mean total bilirubin level on postoperative day (POD) 7 is 13.8±9.3 mg/dl in control group and 7.0±3.3 mg/dl in venoplasty group (P<0.05). Mean amount of ascites on POD 7 and 14 are 1576±1113 and 1397±1661 cc in control group, and 736±416 and 550±385 cc in venoplasty group, respectively (P<0.05). Two-year survival rate is 75.2% in control group and 86.6% in venoplasty group (P<0.05). Conclusions. We conclude that in LDALT using left lobe graft, HV-IVC reconstruction with graft venoplasty and IVC cavoplasty is useful not only to prevent outflow block but also to improve graft function.

AB - Background. Hepatic venous reconstruction is critical in living donor adult liver transplantation (LDALT) because outflow obstruction in small for size graft may lead to graft dysfunction or loss. We describe the usefulness of venoplasties of the graft hepatic vein (HV) and graft HV-recipient inferior vena cava (IVC) reconstruction in LDALT using a left lobe graft. Methods. Sixty patients who underwent LDALT were studied. We divided the patients into following two groups: venoplasty group (n=30) and control group (n=30). For the patients with venoplasty group, venoplasty of the graft and recipient IVC cavoplasty was made to widen the orifice. Comparison examination of a background factors and postoperative bilirubin and the ascites was carried out. Results. The mean graft volume standard liver volume ratio (GV/SLV) did not have the difference at 41.7% of venoplasty group, and 42.1% of control group (p=NS). The diameter of the hepatic vein in control and venoplasty group before and after venoplasty is 26.9±5.5, 28.2±2.9, and 34.1±3.9 mm, respectively. The diameter of the hepatic vein after venoplasty is larger than that of before venoplasty and of control (P<0.05). Mean total bilirubin level on postoperative day (POD) 7 is 13.8±9.3 mg/dl in control group and 7.0±3.3 mg/dl in venoplasty group (P<0.05). Mean amount of ascites on POD 7 and 14 are 1576±1113 and 1397±1661 cc in control group, and 736±416 and 550±385 cc in venoplasty group, respectively (P<0.05). Two-year survival rate is 75.2% in control group and 86.6% in venoplasty group (P<0.05). Conclusions. We conclude that in LDALT using left lobe graft, HV-IVC reconstruction with graft venoplasty and IVC cavoplasty is useful not only to prevent outflow block but also to improve graft function.

UR - http://www.scopus.com/inward/record.url?scp=27644542238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=27644542238&partnerID=8YFLogxK

U2 - 10.1097/01.tp.0000173776.66867.f5

DO - 10.1097/01.tp.0000173776.66867.f5

M3 - Article

C2 - 16249746

AN - SCOPUS:27644542238

VL - 80

SP - 964

EP - 968

JO - Transplantation

JF - Transplantation

SN - 0041-1337

IS - 7

ER -